Synergy Ventures
the creation of a whole that is greater than
the simple sum of its parts.
Synergy Ventures
We are an evergreen venture fund and business strategy think-tank founded and run by successful post exit entrepreneurs. Over the last decade, our principals have helped build disruptive high growth start ups to post IPO companies. We are active strategists who invest our own capital + expertise to help increase value in our portfolio companies.
We focus in early stage consumer brands, disruptive technologies and healthcare.
noun I Syn·er·gy + noun I Ven·ture
50 years of combined experience, multiple exits and tested strategies; we've learned first hand that mastery of an idea, service or product alone is not enough. Today's businesses and startups require an equal mastery of branding, operations, strategy and finance to support and excel any product or service into ultimate success. Our investment philosophy is to provide capital to ideas, entrepreneurs and companies in in combination with our value add expertise.
+$20mm invested to date I 18 companies I 5 operational businesses I 8 exits
Portfolio
A development-stage medical device company using a novel and proprietary platform technology called Nano-Pulse Electro-Signaling (NPES).
Ocugen is a clinical stage biopharmaceutical company developing novel treatments for sight threatening diseases including ocular graft versus host disease, retinitis pigmentosa, geographic atrophy, wet age-related macular degeneration and diabetic retinopathy.
ENDRA Life Sciences is bringing new capabilities to ultrasound through Photo-Acoustic solutions which help medical researchers screen and modify disease models with unparalleled quality and speed.
Through dedication and innovation, Second Sight's mission is to develop, manufacture and market implantable visual prosthetics to enable blind individuals to achieve greater independence.
Through dedication and innovation, Second Sight's mission is to develop, manufacture and market implantable visual prosthetics to enable blind individuals to achieve greater independence.
Our Mission is to eliminate the inefficiency, costs and toxic waste associated with conventional smelter based recycling of Lead Acid Batteries. Our breakthrough, AquaRefining, delivers a better product, at a higher yield, eliminates toxic waste, reduces permitting and is less expensive to build than smelting.
ClearSign develops technology intended to increase energy efficiency and emissions standards of combustion systems, primarily industrial and commercial boilers and furnaces.
Ideal Power Inc. (Ideal Power) designs, markets and sells electrical power conversion products using its Power Packet Switching Architecture (PPSA) technology.
Top up your oxygen levels with OXiGEN™ water and shot for all natural energy, mental clarity and faster recovery from all of life’s stresses.
Precision biologic immnotherapies for immuno oncology, autoimmunity and other diseases.
InnoPharma develops complex generic and innovative specialty pharmaceutical drug products in a high quality, time efficient and cost effective manner.
TesoRx is a pharmaceutical platform company developing treatments that address unmet needs in markets with significant commercial upside.
Cytecare is led by a team of professionals with over 100+ person-years of experience in leading healthcare and life sciences businesses globally, including Asia, Africa and in India. Recognising the significant gap in quality of cancer care and use of standard, evidence-based protocols in cancer therapy in India, they saw the opportunity to bring in global best practices that is aimed at better clinical outcomes while also focusing on individual patient needs. Cytecare aims to revolutionize can
